Also known as: Ligandrol
LGD-4033, also known as Ligandrol, is a potent selective androgen receptor modulator (SARM) that falls under the category of anabolic and myostatin peptides. Developed to treat conditions such as muscle wasting and osteoporosis, LGD-4033 is designed to selectively target androgen receptors in muscle and bone tissues, promoting anabolic activity while minimizing androgenic effects in other tissues.
This compound has gained attention in the research community for its potential applications in enhancing muscle mass and strength, making it a subject of interest for both clinical and athletic research.
LGD-4033 operates by binding to androgen receptors in muscle and bone, mimicking the effects of testosterone without the associated side effects of traditional anabolic steroids. This selective action allows for increased protein synthesis, leading to muscle growth and improved bone density.
By activating androgen receptors, LGD-4033 promotes anabolic processes, enhancing muscle hypertrophy and strength gains while also supporting bone health. Its selectivity is key, as it reduces the risk of unwanted side effects commonly associated with non-selective anabolic agents.
LGD-4033 is a selective androgen receptor modulator with promising applications in muscle and bone health. Its targeted action offers potential benefits for muscle growth and strength enhancement, making it a valuable subject in both clinical and athletic research.
Last updated: Feb 25, 2026